October is Liver Cancer Awareness Month

For Fibronostics

It’s time to think about your liver!

For the fifth year in a row the American Liver Foundation  has partnered with Bayer Healthcare to raise public awareness about the risk of liver cancer and to encourage those at risk to follow up with their doctors and get proper ongoing screening for one of the deadliest forms of cancer. 


The liver is one of the largest organs in the body. It filters harmful substances from the blood, produces bile that helps in the digestion of fats, and stores sugar that the body uses for energy, consequently a healthy liver is key to overall health. 


Here are 5 things you should know about liver disease: 

• The American Liver Foundation says more than 100 million Americans are estimated to have nonalcoholic fatty liver disease (NAFLD), which is only one of dozens diseases that affect the liver. 

• NAFLD is the most common form of liver disease in children and has more than doubled over the past 20 years, according to a study in the journal PLOS One.

• The National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program estimates that 40,710 new cases of liver and intrahepatic bile duct cancer will be diagnosed in the United States and some 28,920 people are expected to die of primary adult liver cancer in 2018. 

• SEER data shows that the five-year survival rate is just 6 percent. It’s also one of the few types of cancer that’s on the rise. 

• Among women, Hispanic women had the highest rates of getting liver cancer (7.5 per 100,000 women), followed by Asian/Pacific Islander women (6.8), American Indian/Alaska Native women (6.1), black women (5.3), and white women (3.9). 

If you are at risk of liver disease, ask your doctor if liver screening is right for you. LiverFASt is a noninvasive liver disease screen for early detection of fatty liver, non-alcoholic steatohepatitis (NASH) and fibrosis. It is simple, less expensive test that offers greater confidence in determining a patient’s level of liver injury and stage of liver disease. For more information contact us today for more information on the LiverFASt™ diagnostic test!